A comparison of timing and patterns of treatment failure, and survival outcomes after progression between HPV+ and HPV- patients undergoing chemoradiation for oropharyngeal squamous cell carcinomas.
Francisco LaxaguePeter Y F ZengDorsa ZabihiNaif FnaisMohammed AlshahraniKevin FungS Danielle MacNeilAdrian MendezJohn YooJoseph S MymrykJohn W BarrettDavid A PalmaAnthony Charles NicholsPublished in: Head & neck (2023)
HPV+ OPSCC patients relapse later compared to HPV- patients in local/locoregional and distant sites. HPV+ patients with local/locoregional recurrence experience superior survival after recurrence, which does not hold true for isolated regional recurrences or distant metastases. These data can be useful to inform prognosis and guide treatment decisions in patients with recurrent OPSCC.
Keyphrases
- high grade
- end stage renal disease
- patients undergoing
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- squamous cell
- free survival
- rectal cancer
- radiation therapy
- cervical cancer screening
- electronic health record
- deep learning
- artificial intelligence
- combination therapy
- replacement therapy
- patient reported